Evaluation of the Use of Levemir® in Insufficiently Controlled Patients With Type 1 or Type 2 Diabetes
NCT01542463 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4464
Last updated 2016-03-03
Summary
This study conducted in Europe. The aim of this study is to evaluated the use of insulin detemir (Levemir®) in insufficiently controlled patients with type 1 or type 2 diabetes.
Conditions
- Diabetes
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
Interventions
- DRUG
-
insulin detemir
Prescribed at the discretion of the physician
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-09-30
- Primary Completion
- 2007-07-31
- Completion
- 2007-07-31
Countries
- Germany
Study Locations
More Related Trials
-
Observational Study to Evaluate the Safety of Levemir® in Diabetes
NCT00659295 ·Status: COMPLETED
-
Observational Study to Evaluate Safety of Levemir® in Type 1 and Type 2 Diabetes
NCT00700765 ·Status: COMPLETED
-
Observational Study to Observe the Efficacy of Levemir® (Insulin Detemir) in Patients With Type 2 Diabetes.
NCT00793273 ·Status: COMPLETED
-
Observational Study to Evaluate the Safety of Levemir® in Diabetes
NCT00706017 ·Status: COMPLETED
-
Observational Study to Evaluate the Safety of Levemir® in Patients With Diabetes
NCT01545791 ·Status: COMPLETED
-
Observational Study on Levemir® in Obese Diabetic Patients
NCT00849342 ·Status: COMPLETED
-
Observational Study on the Weight Effect of Insulin Detemir (Levemir®) in Type 2 Diabetics
NCT00697450 ·Status: COMPLETED
-
Observational Study of Glycaemic Control in Patients Uncontrolled on Oral Antidiabetic Agents and Starting With 1 (Once) Daily Levemir® (Insulin Detemir) as the Treatment of Type 2 Diabetes Mellitus
NCT00687284 ·Status: COMPLETED
-
Observational Study to Evaluate the Safety While Using Levemir®
NCT00701155 ·Status: COMPLETED
-
Observational Study of Safety and Efficacy of Levemir® in Type 2 Diabetes
NCT00687063 ·Status: COMPLETED
-
Observational Study to Evaluate the Safety and Efficacy of Levemir® in Type 2 Diabetes
NCT00700830 ·Status: COMPLETED
-
Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 Diabetes
NCT00264901 ·Status: COMPLETED ·Phase: PHASE4
-
Observational Safety Study in Subjects Using Levemir® (Insulin Detemir) for the Treatment of Type 2 Diabetes Mellitus
NCT00709475 ·Status: COMPLETED
-
Lantus Versus Levemir Treat-To-Target
NCT00405418 ·Status: COMPLETED ·Phase: PHASE4
-
Observational Study to Observe the Safety of Levemir® Treatment in Patients With Type 2 Diabetes
NCT00735501 ·Status: COMPLETED
-
The Impact of Initiating/Switching to Insulin Detemir on Emotional Well-being and Treatment Satisfaction
NCT01542476 ·Status: COMPLETED
-
Observational Study on Safety of Self-titration of Once Daily Levemir®
NCT00740519 ·Status: COMPLETED
-
Observational Study in Type 2 Diabetics Failing on Oral Antidiabetic Therapy and Starting on Insulin Treatment
NCT00865397 ·Status: COMPLETED
-
Observational Study in Type 2 Diabetics Treated by an Intensive Insulin Treatment of Levemir®
NCT00806897 ·Status: COMPLETED
-
Observational Study on Treatment Satisfaction of Levemir® Versus Protaphane® During "Real-life" Usage in Germany
NCT00665808 ·Status: COMPLETED
-
Observational Study in Type 2 Diabetes Treated by an Intensive Insulin Treatment (ICT) Containing Once Daily Levemir® (Insulin Detemir)
NCT00657930 ·Status: COMPLETED
-
Observational Study of Patients Using Levemir® or Insulatard® as Start Insulin for Treatment of Diabetes
NCT00715351 ·Status: COMPLETED
-
Within-subject Variability of Insulin Detemir in Healthy Volunteers
NCT01497535 ·Status: COMPLETED ·Phase: PHASE1
-
Observational Study of Patients With Diabetes Using Levemir® FlexPen®
NCT00670683 ·Status: COMPLETED
-
Observational Study of Type 2 Diabetes Patients Failing on Oral Anti-diabetic Agents Initiated on Levemir® or Insulatard®
NCT00658099 ·Status: COMPLETED